Search

Nagraj Mani

from Natick, MA
Get Report
Also known as:
Mani Nagraj, Nagraj A Mani, Nagra J Mani
Phone and address:
1 Bayberry Rd, Natick, MA 01760
(508) 651-1361
Connected to:
Aditya Mani, 46Annamalai Mani, 43Anu K Mani, 58Arjet Mani, 38Ashwini Mani, 63Behrang Mani, 69Charu Mani, 54Dev Mani, 55Dion A Mani, 47Gautam Mani, 53

Nagraj Mani Phones & Addresses

  • 1 Bayberry Rd, Natick, MA 01760 (508) 651-1361
  • 19 Central St, Somerville, MA 02143 (617) 776-6745
  • Normal, IL

Work

Company: Vertex pharmaceuticals inc. Oct 2008 Position: Senior scientist

Industries

Biotechnology

Resumes

Resumes

Nagraj Mani Photo 1

Senior Scientist At Vertex Pharmaceuticals

Position:
Senior Scientist at Vertex Pharmaceuticals Inc.
Location:
Greater Boston Area
Industry:
Biotechnology
Work:
Vertex Pharmaceuticals Inc. since Oct 2008
Senior Scientist
Vertex Pharmaceuticals 2001 - 2009
Senior Scientist
Vertex Pharmaceuticals Inc 2004 - 2008
Research Scientist II
Vertex Pharmaceuticals Inc 2001 - 2004
Research Scientist I
Tufts University Medical School Jul 1997 - Jun 2001
Post doc

Publications

Us Patents

Combination Therapy For The Treatment Of Hcv Infection

US Patent:
8258116, Sep 4, 2012
Filed:
May 5, 2008
Appl. No.:
12/598802
Inventors:
Ann Kwong - Cambridge MA, US
Nagraj Mani - Natick MA, US
Yi Zhou - Lexington MA, US
Chao Lin - Winchester MA, US
Assignee:
Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:
A01N 43/04
A61K 31/70
US Classification:
514 49, 514 43, 514 50, 514 51
Abstract:
The present invention relates to therapeutic combinations comprising a protease inhibitor and a polymerase inhibitor for the treatment of HCV. The present invention also relates to therapeutic combinations comprising VX-950 and a polymerase inhibitor. Also within the scope of the invention are methods using the therapeutic combinations of the present invention for treating HCV infection or alleviating one or more symptoms thereof in a patient. The present invention also provides kits comprising the combinations of the present invention.

Combination Therapy For The Treatment Of Hcv Infection

US Patent:
20120295843, Nov 22, 2012
Filed:
Aug 1, 2012
Appl. No.:
13/564286
Inventors:
Ann Kwong - Cambridge MA, US
Nagraj Mani - Natick MA, US
Yi Zhou - Lexington MA, US
Chao Lin - Winchester MA, US
Assignee:
VERTEX PHARMACEUTICALS INCORPORATED - Cambridge MA
International Classification:
A61K 38/08
A61P 31/14
US Classification:
514 43, 514 218
Abstract:
The present invention relates to therapeutic combinations comprising a protease inhibitor and a polymerase inhibitor for the treatment of HCV. The present invention also relates to therapeutic combinations comprising VX-950 and a polymerase inhibitor. Also within the scope of the invention are methods using the therapeutic combinations of the present invention for treating HCV infection or alleviating one or more symptoms thereof in a patient. The present invention also provides kits comprising the combinations of the present invention.

Antibacterial Compounds

US Patent:
58887210, Mar 30, 1999
Filed:
Jul 3, 1996
Appl. No.:
8/674831
Inventors:
David Rothstein - Lexington MA
Nagraj Mani - Somerville MA
Assignee:
Millennium Pharmaceuticals, Inc. - Cambridge MA
International Classification:
C12Q 104
C12Q 102
A61K 31425
C07C22900
US Classification:
435 4
Abstract:
The invention features two novel antibiotics, termed 15352A and 15352B, having the structures shown in the figures.
Control profile
Nagraj Mani from Natick, MA Get Report